The National Comprehensive Cancer Network (NCCN), an alliance of 33 cancer centers in the United States, is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries (LMICs) at the upcoming World Congress on Thyroid Cancer, in London.

During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care. As part of that work, the non-profit alliance of leading cancer centers recently published the new NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework) for Thyroid Carcinoma, available free-of-charge at NCCN.org/global. The new resource will debut in front of more than 1,000 cancer care providers from across the globe on June 17, 2023.

NCCN Framework exists for numerous cancer types—covering more than 80 percent of cancer diagnoses—plus supportive care topics such as pain management, palliative care, and breast cancer prevention and detection. The NCCN Framework for Thyroid Carcinoma is the first new cancer type to be added to this library in recent years.

More than 500,000 people are diagnosed with thyroid cancer worldwide every year. The NCCN Framework for Thyroid Carcinoma provides guidance on the optimal treatment approach for differentiated thyroid cancers in resource-constrained settings.